Bayer Aktiengesellschaft Stock Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.09B 50.46B | Sales 2025 * | 47.95B 51.38B | Capitalization | 26.87B 28.79B |
---|---|---|---|---|---|
Net income 2024 * | 2.08B 2.23B | Net income 2025 * | 3.17B 3.39B | EV / Sales 2024 * | 1.27 x |
Net Debt 2024 * | 33.1B 35.47B | Net Debt 2025 * | 29.67B 31.8B | EV / Sales 2025 * | 1.18 x |
P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
8.41
x | Employees | - |
Yield 2024 * |
0.4% | Yield 2025 * |
0.85% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+25.41% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.89% | 236B | |
+5.59% | 198B | |
-9.33% | 194B | |
-3.69% | 149B |